This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

2 Sectors That May Be Past Their Peak

Stocks in this article: IBB IVV TAN SCTY TSLA

NEW YORK (FMD Capital Management) -- The majority of stocks have just barely poked their head above the flat line so far for 2014.

While the market has yet to springboard to new highs, equities have still been remarkably resilient to bounce back from a modest selloff in January. The majority of investors are trying to determine whether or not stocks can leapfrog these levels or if we will see another retest of the lows.

However, that story does not translate for every sector of the economy. Areas such as biotechnology and solar stocks have been on a remarkable run for well over a year now that has translated into triple-digit gains for investors that have stayed the course. These stocks are continuing to show amazing strength and are still breaking out to new highs this week.

So the question now becomes, is this an ideal area to add new money or should you start thinking about scaling back your position size?

The iShares NASDAQ Biotechnology ETF (IBB) produced gains of 32% in 2012, 65.51% in 2013, and has already gained another 20% to start 2014. IBB has over $5 billion invested in 123 companies focused on developing new innovative pharmaceutical and medical devices.

Biotechnology stocks are known to be more volatile because of their hit-or-miss business models, which often lead to periods of strong outperformance or underperformance. Often their stocks are affected by factors such as Food and Drug Administration approval, drug trials, R&D costs, legal fees, and a host other unforeseen events. However, they can also lead to big profits when new products are developed and successfully tested.

This exchange-traded fund has truly been on a sky-high adventure that has produced excellent returns for those that got in early. I am hesitant to use the term "bubble" to describe this sector, but it does show signs of valuations becoming stretched and prices hitting extremes. Consider that IBB has a price to earnings ratio of 41.86 (as of Jan. 31) which is almost double the iShares Core S&P 500 ETF (IVV) reading of 21.73.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs